Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1
5-Year Impact Factor – 2.2
Scopus CiteScore – 3.4 (CiteScore Tracker 3.4)
Index Copernicus  – 161.11; MEiN – 140 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2013, vol. 22, nr 3, May-June, p. 449–450

Publication type: letter to editor

Language: English

Effect of Garlic Extract on Blood Glucose Level and Lipid Profile in Normal and Alloxan Diabetic Rabbits

Wpływ wyciągu z czosnku na stężenie glukozy we krwi i profil lipidowy u królików zdrowych i chorych na cukrzycę wywołaną alloksanem

Hamid Nasr1,

1 Department of Nephrology, Division of Nephropathology, Isfahan University of Medical Sciences, Isfahan, Iran

References (14)

  1. Sher A, Fakhar-Ul-Mahmood M, Shah SN, Bukhsh S, Murtaza G: Effect of garlic extract on blood glucose level and lipid profile in normal and alloxan diabetic rabbits. Adv Clin Exp Med 2012, 21(6), 705–711.
  2. Tolouian R, Hernandez GT: Prediction of Diabetic Nephropathy: The need for a sweet biomarker. J Nephropathol 2013, 2(1), 4–5.
  3. Rahimi Z: ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy. J Nephropathol 2012, 1(3), 143–151.
  4. Rouhi H, Ganji F: Effect of N-acetyl cysteine on serum Lipoprotein (a) and proteinuria in type 2 diabetic patients. J Nephropathol2013, 1(3), 61–66.
  5. Baradaran A: Lipoprotein(a), type 2 diabetes and nephropathy; the mystery continues. J Nephropathol 2012,1(3), 126–129.
  6. Nasri H, Nematbakhsh M, Rafieian-Kopaei M: Ethanolic Garlic Extract Attenuates Gentamicin-induced Nephrotoxicity in Wistar Rats. Iran J Kidney Dis 2013, in press.
  7. Rafieian-Kopaei M, BaradaranA, Merrikhi A, Nematbakhsh M, Madihi Y, Nasri H: Efficacy of Co-administration of Garlic Extract and Metformin for Prevention of Gentamicin-Renal Toxicity in Wistar Rats: A Biochemical Study. Inter J Prev Med 2013, 4(3), 258–264.
  8. Tavafi M: Diabetic nephropathy and antioxidants. J Nephropathol 2013, 2(1), 20–27.
  9. Khajehdehi P.T: Reemerging of a neglected Asian traditional remedy. J Nephropathol 2012, 1(1), 17–22.
  10. Sahni N, Gupta KL: Dietary antioxidents and oxidative stress in predialysis chronic kidney patients. J Nephropathol 2012, 1(3), 134–142.
  11. Hundal RS, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, et al.: Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 2000, 49(12), 2063–2069.
  12. Morales AI, Detaille D, Prieto M, Puente A, Briones E, Arevalo M, et al.: Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway. Kidney Int 2010, 77(10), 861–869.
  13. Amini FG, Rafieian-Kopaei M, Nematbakhsh M, Baradaran A, Nasri H: Ameliorative effects of metformin on renal histologic and biochemical alterations of gentamicin-induced renal toxicity in Wistar rats. J R es Med Sci 2012, 17, 621–625.
  14. Bruckbauer A, Zemel MB: Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity. Diabetes Metab Syndr Obes 2013, 6, 93–102.